Market Herald logo

Subscribe

Be the first with the news that moves the market
  • ScreenPro (SCRN) administered approximately 21,500 Covid-19 tests in June
  • The company provided testing services to twenty-three film and production companies in June
  • ScreenPro Security is a medical technology company that offers proprietary testing methods and medical alerting software
  • ScreenPro Security Inc. (SCRN) opened trading at C$0.03

ScreenPro (SCRN) administered approximately 21,500 Covid-19 tests in June.

The company provided testing services to twenty-three film and production companies in June.

Lena Kozovski, CEO of ScreenPro, commented on the updates.

“We are pleased to continue our partnerships within the film and production industry for administering their Covid testing needs. As Canadians face a seventh wave of Covid, ScreenPro is there to provide a solution for testing and contact tracing needs with our nursing and lab staff. As the Company continues to expand, our core business in testing continues to hold great momentum.”

ScreenPro is a screening and medical technology company that provides turnkey screening solutions with its proprietary medical alerting software.

ScreenPro’s access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allows ScreenPro to provide COVID testing solutions across Canada.

ScreenPro has its own medical doctor and nursing professionals with on-the-ground support staff and transportation, with access to high-quality PPEs to ensure that clients are protected in all aspects of their testing needs.

ScreenPro Security Inc. (SCRN) opened trading at C$0.03 per share.

More From The Market Herald

" Rogers (TSX:RCI.A), Shaw (TSX:SJR.A) and Quebecor (TSX:QBR.A) sign agreement to sell Freedom Mobile

Rogers Communications (RCI.A), Shaw Communications (SJR.A) and Quebecor (QBR.A) have signed an agreement to sell Freedom Mobile.

" Braveheart (TSXV:BHT) closes $65,650 financing

Braveheart Resources (BHT) has closed a financing for proceeds of $65,650.
Medicenna - President and CEO, Fahar Merchant.

" Medicenna (TSX:MDNA) closes US$20 million public offering

Medicenna Therapeutics Corp. (MDNA) has closed its

" Titan Medical (TSX:TMD) reports Q2 2022 financial results

Titan Medical (TMD) released financial results for the three and six months ended June 30, 2022.